BGB Group (BGB), a distinguished healthcare commercialization and communications firm headquartered in New York City with additional offices in Washington DC, Boston, and London, has revealed a strategic partnership with Scrum50 (S50). Scrum50, a dynamic and agile-first creative agency located…
Data from the inaugural US-wide single-center experience at St. Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session during the AF Symposium 2024 in Boston, demonstrates that Left Atrial Appendage Occlusion (LAAO) procedures, strategically planned using FEops…
Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid regurgitation (TR) in the United States. The EVOQUE system is…
Unveiling the New Brand: Making its debut at SLAS, Revvity introduces its fresh brand, emphasizing the ongoing commitment to pushing the boundaries of human potential through scientific innovation. The revitalized company showcases a range of specialized technologies and expertise geared…
SCIEX, a renowned global provider of analytical technologies in the life sciences, has unveiled the Echo® MS+ system during SLAS 2024. This cutting-edge system integrates the proprietary Acoustic Ejection Mass Spectrometry technology with Open Port Interface (OPI) sampling, leveraging the…
Solidifying its standing as the premier independent provider of health solutions, technology, and pharmacy benefit management, MedImpact expands through strategic acquisition MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit management in the nation,…
everaging Advanced Imaging and Innovative Artificial Intelligence, the Latest Diagnostic System Enhances Cervical Cancer Screening Accuracy, Workflow Efficiency, and Patient Care Hologic, Inc. (Nasdaq: HOLX) has announced that its groundbreaking Genius™ Digital Diagnostics System, featuring the Genius™ Cervical AI algorithm,…
Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to pioneering transformative medicines for neurological diseases, has officially granted inducement awards to five new employees. The Compensation Committee of the Board of Directors at Longboard has approved non-qualified stock options, totaling 145,475…
For Exclusive Distribution to GB Trade and Medical Media REZZAYO® (rezafungin) is approved for treating invasive candidiasis in adults. Adherence to official guidelines regarding the appropriate use of antifungal agents is recommended.2 The marketing authorization stems from favorable outcomes in…
Takeda’s Chief Financial Officer Costa Saroukos Announces Departure; Milano Furuta to Assume Role Effective April 1, 2024 TOKYO, Japan — In an announcement today, Takeda disclosed that Costa Saroukos, the current Chief Financial Officer, has made the decision to resign…
Atara Biotherapeutics and Pierre Fabre Laboratories Publish Data from Phase 3 ALLELE Tab-cel® Trial in The Lancet Oncology” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, and Pierre Fabre Laboratories, a global player in oncology responsible for the…
Solidsoft Reply, a subsidiary of the Reply Group specializing in crafting business solutions on the Microsoft Azure cloud, has successfully migrated Finland’s National Medicines Verification System to its National Blueprint solution. Designed to comply with the EU Falsified Medicines Directive…